Skip to main content
JAMA Network logoLink to JAMA Network
. 2020 May 11;77(5):655. doi: 10.1001/jamaneurol.2020.0749

Correction to Collaborator’s Name

PMCID: PMC8177318  PMID: 32391881

The Original Investigation titled “Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome: A Randomized Clinical Trial,”1 published online March 2, 2020, was corrected to fix the spelling of a collaborator’s name to Katherine Moretz, which had been incorrectly given as Katherine Mortez in the Group Members section. This article was corrected online.

Reference

  • 1.Miller I, Scheffer IE, Gunning B, et al. Dose-ranging effect of adjunctive oral cannabidiol vs placebo on convulsive seizure frequency in dravet syndrome: a randomized clinical trial. JAMA Neurol. Published online March 2, 2020. doi: 10.1001/jamaneurol.2020.0073 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from JAMA Neurology are provided here courtesy of American Medical Association

RESOURCES